{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:23:30Z","timestamp":1794749010440,"version":"4.9.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Brucellosis is a zoonotic disease caused by\n                      <jats:italic>Brucella<\/jats:italic>\n                      spp., namely\n                      <jats:italic>B. melitensis<\/jats:italic>\n                      and\n                      <jats:italic>B. abortus<\/jats:italic>\n                      in humans. Culturing is the gold standard method for diagnosis; however, because\n                      <jats:italic>Brucella<\/jats:italic>\n                      is a slow-growing bacterium, which may delay diagnosis, other faster methods, such as serology, are used. Studies on the correlation between\n                      <jats:italic>Brucella<\/jats:italic>\n                      antibody titers and clinical outcomes are limited. Therefore, this study assessed such correlation and evaluated the correlation between baseline serological results with culture positivity and clinical picture.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients tested positive for\n                      <jats:italic>Brucella<\/jats:italic>\n                      antibodies at baseline and diagnosed with brucellosis between January 2008 and December 2018 were included. Collected data included clinical outcomes, baseline culture positivity (growth in culture), arthralgia, baseline and end of therapy (EOT) temperature, white blood cell count, C-reactive protein level, and erythrocyte sedimentation rate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 695 patients tested for\n                      <jats:italic>Brucella<\/jats:italic>\n                      antibodies, only 94 had positive baseline serology and diagnosed with acute brucellosis, among whom 63 had EOT serology. No significant correlations were found between EOT antibody titers of both\n                      <jats:italic>Brucella<\/jats:italic>\n                      spp. and clinical cure, mortality, length of stay, and duration of therapy. Additionally, no correlations were found between baseline serology and culture positivity, arthralgia, temperature, and other lab values.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Brucella<\/jats:italic>\n                      serology does not correlate with clinical outcomes at EOT nor with culture positivity at baseline. Therefore, healthcare providers are advised to consider the whole clinical picture of a brucellosis patient without relying solely on serological results during follow up and not replace culturing with serology testing alone at the time of diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40794-021-00130-w","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T08:02:56Z","timestamp":1612252976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Lack of correlation of Brucella antibody titers with clinical outcomes and culture positivity of brucellosis"],"prefix":"10.1186","volume":"7","author":[{"given":"Shahad A.","family":"Alsubaie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouq A.","family":"Turkistani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanoud A.","family":"Zeaiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-9094","authenticated-orcid":false,"given":"Abrar K.","family":"Thabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"issue":"4","key":"130_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1590\/0037-8682-0319-2016","volume":"50","author":"FF Tuon","year":"2017","unstructured":"Tuon FF, Cerchiari N, Cequinel JC, Droppa EEH, Moreira SDR, Costa TP, et al. Guidelines for the management of human brucellosis in the state of Parana, Brazil. Rev Soc Bras Med Trop. 2017;50(4):458\u201364. https:\/\/doi.org\/10.1590\/0037-8682-0319-2016.","journal-title":"Rev Soc Bras Med Trop"},{"key":"130_CR2","unstructured":"Corbel MJ. Food and Agriculture Organization of the United Nations, World Health Organization & World Organisation for Animal Health. Brucellosis in humans and animals. Geneva: World Health Organization; 2006."},{"issue":"1","key":"130_CR3","doi-asserted-by":"publisher","first-page":"e0170376","DOI":"10.1371\/journal.pone.0170376","volume":"12","author":"T Akhvlediani","year":"2017","unstructured":"Akhvlediani T, Bautista CT, Garuchava N, Sanodze L, Kokaia N, Malania L, et al. Epidemiological and clinical features of brucellosis in the country of Georgia. PLoS One. 2017;12(1):e0170376.","journal-title":"PLoS One"},{"issue":"10","key":"130_CR4","doi-asserted-by":"publisher","first-page":"e1865","DOI":"10.1371\/journal.pntd.0001865","volume":"6","author":"AS Dean","year":"2012","unstructured":"Dean AS, Crump L, Greter H, Schelling E, Zinsstag J. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6(10):e1865. https:\/\/doi.org\/10.1371\/journal.pntd.0001865.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"130_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/QCO.0b013e3283638104","volume":"26","author":"MP Rubach","year":"2013","unstructured":"Rubach MP, Halliday JE, Cleaveland S, Crump JA. Brucellosis in low-income and middle-income countries. Curr Opin Infect Dis. 2013;26(5):404\u201312. https:\/\/doi.org\/10.1097\/QCO.0b013e3283638104.","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 1","key":"130_CR6","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.ijantimicag.2010.06.014","volume":"36","author":"GF Araj","year":"2010","unstructured":"Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36(Suppl 1):S12\u20137. https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.06.014.","journal-title":"Int J Antimicrob Agents"},{"key":"130_CR7","volume-title":"Brucellosis. StatPearls","author":"ME Smith","year":"2018","unstructured":"Smith ME, Bhimji SS. Brucellosis. StatPearls. Treasure Island: StatPearls Publishing LLC; 2018."},{"issue":"6","key":"130_CR8","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1128\/JCM.40.6.2313.2002","volume":"40","author":"M Almuneef","year":"2002","unstructured":"Almuneef M, Memish ZA. Persistence of Brucella antibodies after successful treatment of acute brucellosis in an area of endemicity. J Clin Microbiol. 2002;40(6):2313.","journal-title":"J Clin Microbiol"},{"issue":"9\u201310","key":"130_CR9","first-page":"487","volume":"49","author":"S Al Dahouk","year":"2003","unstructured":"Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis--a review of the literature. Part I: techniques for direct detection and identification of Brucella spp. Clin Lab. 2003;49(9\u201310):487\u2013505.","journal-title":"Clin Lab"},{"issue":"2","key":"130_CR10","doi-asserted-by":"publisher","first-page":"DC26","DOI":"10.7860\/JCDR\/2016\/15525.7311","volume":"10","author":"S Purwar","year":"2016","unstructured":"Purwar S, Metgud SC, Mutnal MB, Nagamoti MB, Patil CS. Utility of serological tests in the era of molecular testing for diagnosis of human brucellosis in endemic area with limited resources. J Clin Diagn Res. 2016;10(2):DC26\u20139. https:\/\/doi.org\/10.7860\/JCDR\/2016\/15525.7311.","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"130_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0732-8893(02)00426-1","volume":"44","author":"ZA Memish","year":"2002","unstructured":"Memish ZA, Almuneef M, Mah MW, Qassem LA, Osoba AO. Comparison of the Brucella standard agglutination test with the ELISA IgG and IgM in patients with Brucella bacteremia. Diagn Microbiol Infect Dis. 2002;44(2):129\u201332.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"130_CR12","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/j.ijid.2009.05.008","volume":"14","author":"MR Roushan","year":"2010","unstructured":"Roushan MR, Amiri MJ, Laly A, Mostafazadeh A, Bijani A. Follow-up standard agglutination and 2-mercaptoethanol tests in 175 clinically cured cases of human brucellosis. Int J Infect Dis. 2010;14(3):e250\u20133. https:\/\/doi.org\/10.1016\/j.ijid.2009.05.008.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"130_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/infdis\/159.2.219","volume":"159","author":"E Gazapo","year":"1989","unstructured":"Gazapo E, Gonzalez Lahoz J, Subiza JL, Baquero M, Gil J, de la Concha EG. Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up. J Infect Dis. 1989;159(2):219\u201325. https:\/\/doi.org\/10.1093\/infdis\/159.2.219.","journal-title":"J Infect Dis"},{"issue":"4","key":"130_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijid.2004.07.009","volume":"9","author":"S Alsubaie","year":"2005","unstructured":"Alsubaie S, Almuneef M, Alshaalan M, Balkhy H, Albanyan E, Alola S, et al. Acute brucellosis in Saudi families: relationship between brucella serology and clinical symptoms. Int J Infect Dis. 2005;9(4):218\u201324. https:\/\/doi.org\/10.1016\/j.ijid.2004.07.009.","journal-title":"Int J Infect Dis"}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-021-00130-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40794-021-00130-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-021-00130-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T08:18:55Z","timestamp":1612253935000},"score":1,"resource":{"primary":{"URL":"https:\/\/tdtmvjournal.biomedcentral.com\/articles\/10.1186\/s40794-021-00130-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1186\/s40794-021-00130-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-104713\/v1","asserted-by":"object"}]},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Research Committee of The Unit of Biomedical Ethics of Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia (reference 123\u201318).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}